A company with a mission to prevent unintended addiction and overdose
Doctors write over 150 million opioid prescriptions annually to 50 million Americans.
10 million people misuse opioids and over 2 million people are addicted leading to over 60,000 deaths each year, more than from car accidents. Most attempts to combat the problem have focused on treating those already addicted.
The Addinex team is focused on preventing opioid misuse, addiction, and overdose, and treating those with Opioid Use Disorder.
Clinical studies have demonstrated that opioid misuse and addiction are driven by three key drivers.
The Addinex system is designed to help clinicians and patients to counter each of
these key drivers with the goal of stopping the epidemic in its tracks.
Up to 92% of patients have unused pills after surgery according to a study by Johns Hopkins University.
The American Journal of Law and Medicine states that there is a "paucity of trustworthy, current data" in prescribing opioids.
Lack of Disposal
The JHU study found that more than 90% of patients fail to properly dispose of leftover pills leading to over 3 billion opioids annually retained or diverted. 50% of illicitly used pills come from one's own or a friend's medicine cabinet.
Risk of addiction increases with initial time of use. A University of Michigan study found that one in 16 users of opioids become chronic users after just one dose and the risk of prolonged use increases dramatically after 4-5 days. You have a one in five chance of still being on the drug after one year if you take an opioid for just 10 days.
Addinex has developed a low-cost, patented opioid dispensing system to prevent addiction and overdose with:
password-protected dosage access,
real-time patient education,
excess pill destruction, and
data feedback on actual usage patterns.
Like the proven efficacy of seatbelts in cars and helmets for motorcyclists, our device adds a
level of protection for users of a useful, but potentially dangerous product.
Each dose requires a unique passcode that matches only the patient with the device. Passcodes are only released to the actual user and on the prescription's schedule.
The Addinex dispenser does not allow a patient to access the next pill until the minimum time interval has passed based on the prescription. For example, one pill 2-4 times per day allows one pill every six hours
Easy to Use App
All passcodes must be requested through our digital database via our mobile app, web app, text, or call-in service (coming soon). The request process is quick and easy.
The Addinex dispenser has no electronics making it very cost effective. All of the patient specific features of the system are accessed via the related App or other methods.
Addinex's patented device and integrated system offer the following unique benefits to
patients, doctors, insurance companies, pharmacies, and society.
Addiction Cost Savings
According to the U.S. Council of Economic Advisers, medical insurers spend over $65 billion annually on opioid addiction. Greater control over initial opioid usage and elimination of access to excess drugs will result in significant savings to the bottom line.
Doctors write over 150 million opioid prescriptions with 3.3 billion excess pills being retained annually. Since our data can help doctors avoid over-prescribing, insurance companies can save billions of dollars from lower prescribing levels and less diversion of pills for illicit use.
Step 1 : See Your Doctor
For patients who are prescribed opioids for post-surgical pain, your doctor or insurance company may recommend or require the use of the Addinex system to manage your at-home opioid use. Your doctor will determine your specific pain medication, dosage, and duration.
Step 2 : Pharmacist
The pharmacist will fill your prescription using the Addinex system and provide you with both the pill dispenser and a pre-paid disposal mailer.
Step 2 : Addinex App
Simply enter the Addinex dispenser ID and personal ID to gain access to your unique device passcode. Answer a few simple anonymous questions to help Addinex provide you with personalized feedback on usage and pain monitoring.
Step 4 : Dispense Your Pills
Enter the unique passcode obtained from the app for each dose, but no more often than the doctor prescribed. Repeat until pain subsides.
Step 5 : Get Educated
Addinex will provide you with valuable information (e.g., possible side-effects, addiction statistics, etc.) each time you take a dose. We'll monitor your pain levels and suggest consideration of over-the-counter medications as the pain subsides. We'll also warn you when you've been taking more pills than is typical for similar patients.
Step 6 : Return Device
Once your pain subsides, it's time to return the device. To avoid the risk of access to pills by unauthorized users and to keep yourself safe from using the pills in the future without a doctor's oversight, we require that the Addinex dispenser be returned for disposal in our easy-to-use pre-paid mailer which can be deposited into any mailbox. Addinex will alert doctors if patients fail to return the device which could compromise access to future prescriptions.
Co-Founder & CEO
Jay Schiff is a Wall Street veteran who has invested over $1 billion in small and mid-sized businesses. He has managed private investment businesses for Merrill Lynch, a $1 billion private equity firm, and a venture-backed finance company. Mr. Schiff holds a BA in Economics from Cornell University and an MBA in Finance from NYU.
Co-Founder & CTO
Stan Roslyakov started several technology-based companies and is a versatile engineer with experience in mechanical, electrical, and software engineering. He holds both BS and MS degrees in Engineering from NYU.
Christian Melgarejo has worked in tech companies around the world and has over 15 years of experience in developing web and desktop apps. He is currently getting a BS degree in Computer Engineering from Universidad Americana Paraguay.
ThankGod Ajayi has worked on various software programming projects, including electronic health records and HIPAA during and since graduating in 2018 with a BS in Computer Science from Bangalore University.
Michael Genovese, MD
Michael Genovese is the Chief Medical Officer for Acadia Healthcare, a leading provider of behavioral healthcare services that operates a network of 583 behavioral healthcare facilities. Dr. Genovese was a fellow at the NYU/North Shore University Hospital Child and Adolescent Psychiatry Program and he completed residency training at the University of Connecticut School of Medicine. Before beginning his medical studies, Dr. Genovese also earned JD and BA degrees at the University of Pittsburgh .
David Elliot is a medical device and healthcare services executive who has held senior roles in Sales and Marketing at St. Jude Medical and Guidant (each sold for over $25 billion) and CEO/COO positions at several start-up healthcare companies. Dave holds a BA in English from Connecticut College and an MBA in Finance and Marketing from the University of Chicago.
Get in touch with us
Please fill out the following form and we will contact you as soon as possible.